Core Viewpoint - Rosen Law Firm is reminding investors who purchased Nutex Health Inc. securities during the specified Class Period of the upcoming lead plaintiff deadline for a class action lawsuit [1] Group 1: Class Action Details - The Class Period for the Nutex securities is from August 8, 2024, to August 14, 2025, inclusive [1] - Investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] - A class action lawsuit has already been filed, and interested parties must move the Court by October 21, 2025, to serve as lead plaintiff [2] Group 2: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company at the time [3] - The firm was ranked No. 1 by ISS Securities Class Action Services for the number of securities class action settlements in 2017 and has consistently ranked in the top 4 since 2013 [3] - In 2019, the firm secured over $438 million for investors, showcasing its capability in recovering significant amounts for clients [3] Group 3: Case Allegations - The lawsuit alleges that Nutex made false and misleading statements regarding its financial practices and internal controls [4] - Specific claims include that Nutex engaged in fraudulent activities through a third-party vendor, HaloMD, which led to unsustainable revenue [4] - The allegations also state that Nutex overstated its ability to remediate internal control weaknesses and improperly classified stock-based compensation obligations [4]
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Nutex Health Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NUTX